
With
Protiti Bagchi
Associate Director
Dr. Subho Ray, President, IAMAI, speaks with Protiti Bagchi, Associate Director at GSK, on the evolving landscape of pharmaceutical marketing, digital transformation, science communication, and public trust. The conversation explores how pharma companies are leveraging digital channels such as WhatsApp, email, and web marketing to engage healthcare professionals, while balancing innovation with stringent scientific, regulatory, and compliance requirements. It examines the role of doctors and Key Opinion Leaders (KOLs), adverse-event monitoring, patient awareness, and evidence-based communication in addressing public concerns around vaccines and medicines. The discussion also highlights the challenges facing India’s scientific ecosystem, including research infrastructure, industry-academia linkages, talent retention, and the need to build greater capacity for science communication. Offering insights into the intersection of healthcare, technology, marketing, and public policy, the episode underscores the importance of making scientific information accessible and engaging without compromising evidence, accuracy, or public trust.